Position in ATAI
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$227,976
New position
Shares Held
64,400
first reported quarter
Ownership
0.017%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026WINTON GROUP Ltd holds $82,857,367 across 70 Biotechnology names. ATAI ranks #50 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
173,032 | $16,285,771 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,778 | $11,418,073 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
106,532 | $7,999,487 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
47,925 | $3,558,910 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
55,080 | $3,453,516 | |
| 6 | VIR |
Vir Biotechnology, Inc.
|
367,883 | $3,296,231 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
307,096 | $2,892,844 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
69,291 | $2,787,576 |
All Filings in ATAI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $227,976 | 64,400 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||